ARGX |
argenx SE |
31.88B |
5.73% |
|
|
|
|
|
533.10 |
0.76% |
27.93% |
5.11% |
---|
326030.KS |
SK BIOPHARMACEUTICALS LTD |
|
4.47% |
|
|
|
|
|
|
|
|
|
---|
ALKS |
Alkermes plc |
4.66B |
4.41% |
|
|
|
|
|
28.27 |
1.58% |
37.86% |
56.93% |
---|
BHVN |
Biohaven Pharmaceutical Holding Company ... |
3.84B |
4.31% |
|
|
|
|
|
40.59 |
3.02% |
85.62% |
32.47% |
---|
ACAD |
ACADIA Pharmaceuticals Inc. |
2.73B |
4.28% |
|
|
|
|
|
16.47 |
0.86% |
39.20% |
7.45% |
---|
DYN |
Dyne Therapeutics, Inc. |
3.59B |
4.27% |
|
|
|
|
|
35.76 |
4.14% |
57.52% |
15.67% |
---|
SRPT |
Sarepta Therapeutics, Inc. |
12.18B |
4.26% |
|
|
|
|
|
127.74 |
2.18% |
40.23% |
2.28% |
---|
ITCI |
Intra-Cellular Therapies, Inc. |
8.00B |
4.16% |
|
|
|
|
|
75.73 |
1.38% |
32.08% |
3.26% |
---|
XENE |
Xenon Pharmaceuticals Inc. |
3.11B |
4.15% |
|
|
|
|
|
41.08 |
2.46% |
61.72% |
29.82% |
---|
CPRX |
Catalyst Pharmaceuticals, Inc. |
2.49B |
4.13% |
|
|
|
|
|
21.02 |
2.89% |
35.91% |
26.88% |
---|
AXNX |
Axonics, Inc. |
3.54B |
4.03% |
|
|
|
|
|
69.34 |
0.90% |
33.88% |
39.45% |
---|
HLUN-B.CO |
H. LUNDBECK CLASS B |
|
3.89% |
|
|
|
|
|
|
|
|
|
---|
SUPN |
Supernus Pharmaceuticals, Inc. |
1.76B |
3.71% |
|
|
|
|
|
31.98 |
0.44% |
83.41% |
37.35% |
---|
NBIX |
Neurocrine Biosciences, Inc. |
12.27B |
3.53% |
|
|
|
|
|
121.50 |
1.38% |
29.90% |
13.36% |
---|
BIIB |
Biogen Inc. |
29.50B |
3.52% |
|
|
|
|
|
202.49 |
2.48% |
27.31% |
24.65% |
---|
PTCT |
PTC Therapeutics, Inc. |
2.83B |
3.40% |
|
|
|
|
|
36.78 |
3.66% |
41.34% |
10.65% |
---|
AVDL |
Avadel Pharmaceuticals plc |
1.32B |
2.74% |
|
|
|
|
|
13.68 |
0.22% |
98.62% |
79.47% |
---|
SAVA |
Cassava Sciences, Inc. |
1.43B |
2.69% |
|
|
|
|
|
29.87 |
-1.48% |
121.64% |
29.96% |
---|
IART |
Integra LifeSciences Holdings Corporatio... |
1.37B |
2.45% |
|
|
|
|
|
17.69 |
0.91% |
105.53% |
65.91% |
---|
EWTX |
Edgewise Therapeutics, Inc. |
2.64B |
2.35% |
|
|
|
|
|
28.11 |
47.52% |
87.44% |
18.06% |
---|
LBPH |
Longboard Pharmaceuticals, Inc. |
1.24B |
2.28% |
|
|
|
|
|
31.91 |
8.87% |
93.72% |
17.72% |
---|
NEU |
NewMarket Corporation |
5.29B |
2.15% |
|
|
|
|
|
551.06 |
0.55% |
21.49% |
46.35% |
---|
PRTA |
Prothena Corporation plc |
1.17B |
1.98% |
|
|
|
|
|
21.78 |
1.40% |
59.20% |
2.54% |
---|
BIOA-B.ST |
BIOARCTIC CLASS B |
|
1.34% |
|
|
|
|
|
|
|
|
|
---|
NMRA |
Neumora Therapeutics, Inc. Common Stock |
2.06B |
1.20% |
|
|
|
|
|
12.89 |
5.57% |
138.21% |
53.02% |
---|
DNTH |
Dianthus Therapeutics, Inc. |
821.92M |
1.17% |
|
|
|
|
|
28.00 |
7.69% |
109.53% |
47.50% |
---|
SRRK |
Scholar Rock Holding Corporation |
698.28M |
1.13% |
|
|
|
|
|
8.73 |
5.50% |
177.92% |
72.26% |
---|
AXGN |
AxoGen, Inc. |
644.30M |
1.11% |
|
|
|
|
|
14.70 |
0.96% |
103.91% |
19.25% |
---|
WVE |
Wave Life Sciences Ltd. |
734.08M |
1.03% |
|
|
|
|
|
5.89 |
7.59% |
140.61% |
21.57% |
---|
AVXL |
Anavex Life Sciences Corp. |
495.21M |
0.94% |
|
|
|
|
|
5.84 |
6.18% |
93.96% |
-3.01% |
---|
ANNX |
Annexon, Inc. |
740.11M |
0.86% |
|
|
|
|
|
7.01 |
1.08% |
84.23% |
10.28% |
---|
ALEC |
Alector, Inc. |
591.71M |
0.70% |
|
|
|
|
|
6.08 |
7.80% |
339.37% |
47.69% |
---|
LRMR |
Larimar Therapeutics, Inc. |
473.76M |
0.68% |
|
|
|
|
|
7.43 |
8.39% |
115.27% |
31.75% |
---|
ANRO |
Alto Neuroscience, Inc. |
375.81M |
0.59% |
|
|
|
|
|
13.94 |
5.61% |
N/A |
N/A |
---|
VYGR |
Voyager Therapeutics, Inc. |
351.74M |
0.59% |
|
|
|
|
|
6.45 |
3.53% |
15.04% |
57.60% |
---|
TRDA |
Entrada Therapeutics, Inc. |
564.69M |
0.58% |
|
|
|
|
|
15.18 |
11.21% |
178.62% |
82.23% |
---|
VNDA |
Vanda Pharmaceuticals Inc. |
270.76M |
0.57% |
|
|
|
|
|
4.65 |
-6.16% |
63.97% |
50.45% |
---|
SLDB |
Solid Biosciences Inc. |
305.87M |
0.54% |
|
|
|
|
|
7.93 |
10.99% |
122.17% |
59.41% |
---|
PEPG |
PepGen Inc. |
324.59M |
0.47% |
|
|
|
|
|
9.96 |
7.56% |
N/A |
N/A |
---|
0H7R.L |
ABEONA THERAPEUTICS INC |
|
0.46% |
|
|
|
|
|
|
|
|
|
---|
2172.HK |
MICROPORT NEUROTECH CORP |
|
0.38% |
|
|
|
|
|
|
|
|
|
---|
NVRO |
Nevro Corp. |
217.36M |
0.38% |
|
|
|
|
|
5.83 |
0.17% |
135.95% |
40.30% |
---|
268600.KQ |
CELLIVERY THERAPEUTICS INC |
|
0.34% |
|
|
|
|
|
|
|
|
|
---|
NP5.DE |
NEWRON PHARMACEUTICALS |
|
0.33% |
|
|
|
|
|
|
|
|
|
---|
KYTX |
Kyverna Therapeutics, Inc. Common Stock |
305.26M |
0.31% |
|
|
|
|
|
7.08 |
7.20% |
534.10% |
46.24% |
---|
CAPR |
Capricor Therapeutics, Inc. |
164.00M |
0.24% |
|
|
|
|
|
5.04 |
-1.56% |
133.30% |
6.22% |
---|
ABOS |
Acumen Pharmaceuticals, Inc. |
155.31M |
0.20% |
|
|
|
|
|
2.5850 |
5.94% |
191.12% |
24.11% |
---|
AMLX |
Amylyx Pharmaceuticals, Inc. |
200.84M |
0.20% |
|
|
|
|
|
2.9500 |
2.43% |
209.12% |
21.57% |
---|
NPCE |
NeuroPace, Inc. |
206.13M |
0.19% |
|
|
|
|
|
7.06 |
3.52% |
254.61% |
59.21% |
---|
CVRX |
CVRx, Inc. |
205.22M |
0.18% |
|
|
|
|
|
9.42 |
8.40% |
77.42% |
62.79% |
---|
VTGN |
VistaGen Therapeutics, Inc. |
81.30M |
0.16% |
|
|
|
|
|
3.01 |
0.33% |
149.56% |
71.22% |
---|
ATHA |
Athira Pharma, Inc. |
18.04M |
0.04% |
|
|
|
|
|
0.4694 |
1.38% |
326.48% |
61.22% |
---|